Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
BMC Psychiatry|June 24, 2026
Right broca homologue mediates the pain-depression circuit: a case-control Functional Near-Infrared Spectroscopy (fNIRS) study on language network remodeling in chronic pain-depression comorbidityJiaren Zheng, Ning Zhu, Jiaxi Huang, et al.
Frontiers in Pediatrics|August 2, 2024
Predicting postoperative pain in children: an observational study using the pain threshold IndexZenghui Liang, Yanle Xie, Shuhan Chen, et al.
Nature Communications|October 7, 2023
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trialMin Yan, Limin Niu, Huimin Lv, et al.
BMC Anesthesiology|February 15, 2024
Effectiveness of perioperative low-dose esketamine infusion for postoperative pain management in pediatric urological surgery: a prospective clinical trialYanle Xie, Zenghui Liang, Shuhan Chen, et al.
Communications Biology|July 13, 2026
Ex utero 3D culture system illuminates post-implantation development and functions of the mouse yolk sacShanshan Jin, Yuxiang Liang, Zhaowei Yu, et al.
JAMA Oncology|June 26, 2025
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical TrialMin Yan, Huimin Lv, Xinlan Liu, et al.
International Journal of Molecular Medicine|November 3, 2010
T lymphocyte responses against hepatitis B virus-related hepatocellular carcinoma induced by adenovirus vaccine encoding HBxYuhua Li, Ping Cheng, Yanjun Wen, et al.
BMC Medicine|January 28, 2026
Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 studyHuimin Lv, Tao Sun, Xiaoling Ling, et al.
Advanced Healthcare Materials|February 5, 2024
Incorporation of Decidual Stromal Cells Derived Exosomes in Sodium Alginate Hydrogel as an Innovative Therapeutic Strategy for Advancing Endometrial Regeneration and Reinstating FertilityYuxiang Liang, Qizhi Shuai, Xiao Zhang, et al.
Experimental & Molecular Medicine|August 30, 2022
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axisJunqing Gan, Shan Liu, Yu Zhang, et al.
Pageof 6